SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-012897
Filing Date
2019-01-18
Accepted
2019-01-18 16:06:05
Documents
6
Period of Report
2019-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d684265d8k.htm 8-K 23133
2 EX-10.1 d684265dex101.htm EX-10.1 78889
3 EX-10.2 d684265dex102.htm EX-10.2 35534
4 EX-10.3 d684265dex103.htm EX-10.3 10338
5 GRAPHIC g684265snap0001.jpg GRAPHIC 4553
6 GRAPHIC g684265sp28.jpg GRAPHIC 2952
  Complete submission text file 0001193125-19-012897.txt   159756
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 19533336
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1